In the present study, we constructed FA-mExo-siRNA-c-kit and firstly verified the targetability to gefitinib resistant lung cancer cells and the anti-tumor effects including decreasing stemness and inducing apoptosis in vitro. This evidence concerns the gene KIT and lung carcinoma.